Clinical Focus ›› 2021, Vol. 36 ›› Issue (11): 1013-1018.doi: 10.3969/j.issn.1004-583X.2021.11.011
Previous Articles Next Articles
Yuan Shichao, Zhao Qing, Fan Hongyan()
Received:
2021-02-18
Online:
2021-11-20
Published:
2021-12-01
Contact:
Fan Hongyan
E-mail:455573357@qq.com
CLC Number:
Yuan Shichao, Zhao Qing, Fan Hongyan. Predictive value of dual-energy CT for Ki-67 expression in gastric stromal tumors and relationship with pathological factors[J]. Clinical Focus, 2021, 36(11): 1013-1018.
项目 | 高表达组(n=39) | 低表达组(n=43) | t值 | P值 |
---|---|---|---|---|
动脉期 | ||||
40 ke V CT值(HU) | 172.25±13.65 | 116.38±12.33 | 19.475 | <0.01 |
50 ke V CT值(HU) | 125.49±21.74 | 85.54±10.19 | 10.816 | <0.01 |
60 ke V CT值(HU) | 93.31±12.27 | 64.28±10.10 | 11.739 | <0.01 |
70 ke V CT值(HU) | 74.59±13.35 | 52.47±12.24 | 7.828 | <0.01 |
IC值(×102μg/cm3) | 15.25±2.68 | 10.16±2.37 | 9.127 | <0.01 |
NIC值 | 0.18±0.09 | 0.10±0.02 | 5.680 | <0.01 |
静脉期 | ||||
40 ke V CT值(HU) | 180.46±21.63 | 141.12±29.68 | 6.799 | <0.01 |
50 ke V CT值(HU) | 128.53±16.39 | 100.25±15.51 | 8.026 | <0.01 |
60 ke V CT值(HU) | 95.74±12.45 | 74.68±10.17 | 8.421 | <0.01 |
70 ke V CT值(HU) | 73.69±15.39 | 60.25±10.28 | 4.689 | <0.01 |
IC值(×102μg/cm3) | 18.96±2.35 | 13.44±1.24 | 13.478 | <0.01 |
NIC值 | 0.37±0.10 | 0.25±0.04 | 7.258 | <0.01 |
平衡期 | ||||
40 ke V CT值(HU) | 181.35±35.46 | 179.85±33.35 | 0.197 | 0.844 |
50 ke V CT值(HU) | 127.49±30.46 | 125.48±32.56 | 0.288 | 0.774 |
60 ke V CT值(HU) | 92.46±15.33 | 90.46±17.19 | 0.554 | 0.581 |
70 ke V CT值(HU) | 72.79±12.36 | 70.59±10.44 | 0.873 | 0.385 |
IC值(×102μg/cm3) | 18.43±2.16 | 17.49±3.22 | 1.536 | 0.128 |
NIC值 | 0.52±0.05 | 0.54±0.07 | 1.475 | 0.144 |
项目 | 高表达组(n=39) | 低表达组(n=43) | t值 | P值 |
---|---|---|---|---|
动脉期 | ||||
40 ke V CT值(HU) | 172.25±13.65 | 116.38±12.33 | 19.475 | <0.01 |
50 ke V CT值(HU) | 125.49±21.74 | 85.54±10.19 | 10.816 | <0.01 |
60 ke V CT值(HU) | 93.31±12.27 | 64.28±10.10 | 11.739 | <0.01 |
70 ke V CT值(HU) | 74.59±13.35 | 52.47±12.24 | 7.828 | <0.01 |
IC值(×102μg/cm3) | 15.25±2.68 | 10.16±2.37 | 9.127 | <0.01 |
NIC值 | 0.18±0.09 | 0.10±0.02 | 5.680 | <0.01 |
静脉期 | ||||
40 ke V CT值(HU) | 180.46±21.63 | 141.12±29.68 | 6.799 | <0.01 |
50 ke V CT值(HU) | 128.53±16.39 | 100.25±15.51 | 8.026 | <0.01 |
60 ke V CT值(HU) | 95.74±12.45 | 74.68±10.17 | 8.421 | <0.01 |
70 ke V CT值(HU) | 73.69±15.39 | 60.25±10.28 | 4.689 | <0.01 |
IC值(×102μg/cm3) | 18.96±2.35 | 13.44±1.24 | 13.478 | <0.01 |
NIC值 | 0.37±0.10 | 0.25±0.04 | 7.258 | <0.01 |
平衡期 | ||||
40 ke V CT值(HU) | 181.35±35.46 | 179.85±33.35 | 0.197 | 0.844 |
50 ke V CT值(HU) | 127.49±30.46 | 125.48±32.56 | 0.288 | 0.774 |
60 ke V CT值(HU) | 92.46±15.33 | 90.46±17.19 | 0.554 | 0.581 |
70 ke V CT值(HU) | 72.79±12.36 | 70.59±10.44 | 0.873 | 0.385 |
IC值(×102μg/cm3) | 18.43±2.16 | 17.49±3.22 | 1.536 | 0.128 |
NIC值 | 0.52±0.05 | 0.54±0.07 | 1.475 | 0.144 |
项目 | AUC | 标准误 | P值 | 95%CI | 敏感度 | 特异度 | 约登指数 | Cut-off值 | |
---|---|---|---|---|---|---|---|---|---|
下限 | 上限 | ||||||||
动脉期 | |||||||||
40 ke V CT值 | 0.998 | 0.002 | 0.000 | 0.994 | 1.000 | 97.4 | 100.0 | 0.974 | 144.875 |
50 ke V CT值 | 0.944 | 0.029 | 0.000 | 0.887 | 1.000 | 89.7 | 93.0 | 0.827 | 99.410 |
60 ke V CT值 | 0.967 | 0.017 | 0.000 | 0.933 | 1.000 | 94.9 | 90.7 | 0.856 | 78.135 |
70 ke V CT值 | 0.888 | 0.035 | 0.000 | 0.821 | 0.956 | 74.4 | 88.4 | 0.628 | 65.265 |
IC值 | 0.925 | 0.028 | 0.000 | 0.869 | 0.981 | 89.7 | 86.0 | 0.757 | 12.385 |
NIC值 | 0.764 | 0.061 | 0.000 | 0.644 | 0.884 | 66.7 | 100.0 | 0.667 | 0.135 |
静脉期 | |||||||||
40 ke V CT值 | 0.867 | 0.040 | 0.000 | 0.789 | 0.945 | 84.6 | 81.4 | 0.660 | 166.32 |
50 ke V CT值 | 0.907 | 0.033 | 0.000 | 0.843 | 0.971 | 89.7 | 81.4 | 0.711 | 113.385 |
60 ke V CT值 | 0.939 | 0.027 | 0.000 | 0.885 | 0.992 | 97.4 | 86.0 | 0.834 | 83.820 |
70 ke V CT值 | 0.758 | 0.054 | 0.000 | 0.652 | 0.863 | 51.3 | 90.7 | 0.420 | 72.080 |
IC值 | 0.952 | 0.027 | 0.000 | 0.899 | 1.000 | 89.7 | 100.0 | 0.897 | 16.375 |
NIC值 | 0.854 | 0.041 | 0.000 | 0.774 | 0.935 | 69.2 | 83.7 | 0.529 | 0.285 |
项目 | AUC | 标准误 | P值 | 95%CI | 敏感度 | 特异度 | 约登指数 | Cut-off值 | |
---|---|---|---|---|---|---|---|---|---|
下限 | 上限 | ||||||||
动脉期 | |||||||||
40 ke V CT值 | 0.998 | 0.002 | 0.000 | 0.994 | 1.000 | 97.4 | 100.0 | 0.974 | 144.875 |
50 ke V CT值 | 0.944 | 0.029 | 0.000 | 0.887 | 1.000 | 89.7 | 93.0 | 0.827 | 99.410 |
60 ke V CT值 | 0.967 | 0.017 | 0.000 | 0.933 | 1.000 | 94.9 | 90.7 | 0.856 | 78.135 |
70 ke V CT值 | 0.888 | 0.035 | 0.000 | 0.821 | 0.956 | 74.4 | 88.4 | 0.628 | 65.265 |
IC值 | 0.925 | 0.028 | 0.000 | 0.869 | 0.981 | 89.7 | 86.0 | 0.757 | 12.385 |
NIC值 | 0.764 | 0.061 | 0.000 | 0.644 | 0.884 | 66.7 | 100.0 | 0.667 | 0.135 |
静脉期 | |||||||||
40 ke V CT值 | 0.867 | 0.040 | 0.000 | 0.789 | 0.945 | 84.6 | 81.4 | 0.660 | 166.32 |
50 ke V CT值 | 0.907 | 0.033 | 0.000 | 0.843 | 0.971 | 89.7 | 81.4 | 0.711 | 113.385 |
60 ke V CT值 | 0.939 | 0.027 | 0.000 | 0.885 | 0.992 | 97.4 | 86.0 | 0.834 | 83.820 |
70 ke V CT值 | 0.758 | 0.054 | 0.000 | 0.652 | 0.863 | 51.3 | 90.7 | 0.420 | 72.080 |
IC值 | 0.952 | 0.027 | 0.000 | 0.899 | 1.000 | 89.7 | 100.0 | 0.897 | 16.375 |
NIC值 | 0.854 | 0.041 | 0.000 | 0.774 | 0.935 | 69.2 | 83.7 | 0.529 | 0.285 |
项目 | Ki-67指数 | |
---|---|---|
r值 | P值 | |
40 ke V CT值 | -0.909 | 0.000 |
50 ke V CT值 | -0.771 | 0.000 |
60 ke V CT值 | -0.795 | 0.000 |
70 ke V CT值 | -0.659 | 0.000 |
IC值 | -0.714 | 0.000 |
NIC值 | -0.539 | 0.000 |
项目 | Ki-67指数 | |
---|---|---|
r值 | P值 | |
40 ke V CT值 | -0.909 | 0.000 |
50 ke V CT值 | -0.771 | 0.000 |
60 ke V CT值 | -0.795 | 0.000 |
70 ke V CT值 | -0.659 | 0.000 |
IC值 | -0.714 | 0.000 |
NIC值 | -0.539 | 0.000 |
项目 | Ki-67指数 | |
---|---|---|
r值 | P值 | |
40 ke V CT值 | -0.909 | 0.000 |
50 ke V CT值 | -0.771 | 0.000 |
60 ke V CT值 | -0.795 | 0.000 |
70 ke V CT值 | -0.659 | 0.000 |
IC值 | -0.714 | 0.000 |
NIC值 | -0.539 | 0.000 |
项目 | Ki-67指数 | |
---|---|---|
r值 | P值 | |
40 ke V CT值 | -0.909 | 0.000 |
50 ke V CT值 | -0.771 | 0.000 |
60 ke V CT值 | -0.795 | 0.000 |
70 ke V CT值 | -0.659 | 0.000 |
IC值 | -0.714 | 0.000 |
NIC值 | -0.539 | 0.000 |
项目 | 高表达组(n=39) | 低表达组(n=43) | χ2值 | P值 |
---|---|---|---|---|
年龄 | ||||
>60岁 ≤60岁 | 21(53.85) 18(46.15) | 23(53.49) 20(46.51) | 0.007 | 0.934 |
肿瘤部位 | ||||
胃部 | 5(12.82) | 20(46.51) | ||
结直肠 | 16(41.03) | 8(18.60) | 20.653 | <0.01 |
小肠 | 5(12.82) | 12(27.91) | ||
其他 | 13(33.33) | 3(6.98) | ||
肿瘤组织类型 | ||||
混合细胞 梭形细胞 | 5(12.82) 34(87.18) | 7(16.28) 36(83.72) | 0.237 | 0.626 |
肿瘤直径 | ||||
>10.0 cm | 6(15.38) | 8(18.60) | ||
5.110.0 cm | 26(66.67) | 26(60.47) | 0.382 | 0.536 |
2.15.0 cm | 5(12.82) | 6(13.95) | ||
≤2.0 cm | 2(5.13) | 3(6.98) | ||
合并肿瘤 | ||||
是 否 | 9(23.08) 30(76.92) | 10(23.26) 33(76.74) | 0.006 | 0.938 |
核分裂象 | ||||
≤5个/50 HPF | 21(53.85) | 39(90.70) | ||
15.110.0个/50 HPF | 5(12.82) | 2(4.65) | 14.592 | <0.0 |
10个/50 HPF | 13(33.33) | 2(4.65) | ||
单发/多发 | ||||
单发 多发 | 11(28.21) 28(71.79) | 29(67.44) 14(32.56) | 13.495 | <0.01 |
有无出血 | ||||
有 无 | 6(15.38) 33(84.62) | 9(20.93) 34(79.07) | 0.490 | 0.484 |
危险度分级 | ||||
高危 | 8(20.51) | 2(4.65) | ||
中危 | 13(33.33) | 8(18.60) | 14.454 | <0.01 |
低危 | 13(33.33) | 15(34.88) | ||
极低危 | 5(12.82) | 18(41.86) |
项目 | 高表达组(n=39) | 低表达组(n=43) | χ2值 | P值 |
---|---|---|---|---|
年龄 | ||||
>60岁 ≤60岁 | 21(53.85) 18(46.15) | 23(53.49) 20(46.51) | 0.007 | 0.934 |
肿瘤部位 | ||||
胃部 | 5(12.82) | 20(46.51) | ||
结直肠 | 16(41.03) | 8(18.60) | 20.653 | <0.01 |
小肠 | 5(12.82) | 12(27.91) | ||
其他 | 13(33.33) | 3(6.98) | ||
肿瘤组织类型 | ||||
混合细胞 梭形细胞 | 5(12.82) 34(87.18) | 7(16.28) 36(83.72) | 0.237 | 0.626 |
肿瘤直径 | ||||
>10.0 cm | 6(15.38) | 8(18.60) | ||
5.110.0 cm | 26(66.67) | 26(60.47) | 0.382 | 0.536 |
2.15.0 cm | 5(12.82) | 6(13.95) | ||
≤2.0 cm | 2(5.13) | 3(6.98) | ||
合并肿瘤 | ||||
是 否 | 9(23.08) 30(76.92) | 10(23.26) 33(76.74) | 0.006 | 0.938 |
核分裂象 | ||||
≤5个/50 HPF | 21(53.85) | 39(90.70) | ||
15.110.0个/50 HPF | 5(12.82) | 2(4.65) | 14.592 | <0.0 |
10个/50 HPF | 13(33.33) | 2(4.65) | ||
单发/多发 | ||||
单发 多发 | 11(28.21) 28(71.79) | 29(67.44) 14(32.56) | 13.495 | <0.01 |
有无出血 | ||||
有 无 | 6(15.38) 33(84.62) | 9(20.93) 34(79.07) | 0.490 | 0.484 |
危险度分级 | ||||
高危 | 8(20.51) | 2(4.65) | ||
中危 | 13(33.33) | 8(18.60) | 14.454 | <0.01 |
低危 | 13(33.33) | 15(34.88) | ||
极低危 | 5(12.82) | 18(41.86) |
项目 | Ki-67指数 | |
---|---|---|
r值 | P值 | |
年龄 | 0.004 | 0.975 |
肿瘤部位 | -0.324 | 0.003 |
肿瘤组织类型 | -0.049 | 0.663 |
肿瘤直径 | 0.011 | 0.922 |
合并肿瘤 | -0.002 | 0.985 |
有无出血 | -0.392 | 0.000 |
危险度分级 | 0.416 | 0.000 |
核分裂象 | -0.418 | 0.000 |
单发/多发 | -0.392 | 0.000 |
项目 | Ki-67指数 | |
---|---|---|
r值 | P值 | |
年龄 | 0.004 | 0.975 |
肿瘤部位 | -0.324 | 0.003 |
肿瘤组织类型 | -0.049 | 0.663 |
肿瘤直径 | 0.011 | 0.922 |
合并肿瘤 | -0.002 | 0.985 |
有无出血 | -0.392 | 0.000 |
危险度分级 | 0.416 | 0.000 |
核分裂象 | -0.418 | 0.000 |
单发/多发 | -0.392 | 0.000 |
[1] | 马卫霞, 于春梅, 孙明霞. 胃肠道间质瘤的CT和MRI特征及其与病理危险度的关系[J]. 癌症进展, 2019, 17(8):942-944, 978. |
[2] | 王泽涛, 陈剑通, 尚国印. Ki67免疫组化染色指数与胃间质瘤临床病理特征及预后的关系[J]. 哈尔滨医科大学学报, 2019, 53(5):513-516. |
[3] | Sahin S, Ekinci O, Seckin S, et al. Proliferation markers RacGAP1 and Ki-67 in gastrointestinal stromal tumors by immunohistochemistry with respect to clinicopathological features and different risk stratification systems[J]. Int J Clin Exp Pathol, 2017, 10(12):11723-11736. |
[4] | 宋学林, 刘玉霞, 杨世锋, 等. 胃肠道间质瘤的MSCT征象与临床病理的对照研究[J]. 医学影像学杂志, 2020, 30(8):1412-1417. |
[5] | 汪明, 曹晖. NCCN《软组织肉瘤临床实践指南(2017年第2版)》胃肠间质瘤内容介绍与更新解读[J]. 中国实用外科杂志, 2017, 37(6):644-648. |
[6] | 赵宇, 刘辉, 习羽, 等. 胃间质瘤CT征象与肿瘤危险度分级的关系[J]. 实用放射学杂志, 2016, 32(6):892-895. |
[7] |
Pyo JS, Kang G, Sohn JH. Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: A systematic review and meta-analysis[J]. Int J Biol Markers, 2016, 31(2):204-210.
doi: 10.5301/jbm.5000183 URL |
[8] | 王帆荣, 陈芸, 李梅, 等. 胃肠道间质瘤中Ki-67表达及其与临床病理特征、危险度分级的相关性[J]. 临床与实验病理学杂志, 2017, 33(9):1022-1025. |
[9] |
Pih GY, Jeon SJ, Ahn JY, et al. Clinical outcomes of upper gastrointestinal bleeding in patients with gastric gastrointestinal stromal tumor[J]. Surg Endosc, 2020, 34(2):696-706.
doi: 10.1007/s00464-019-06816-9 URL |
[10] | 孟建民, 陈立光. 基于增强CT的胃肠道间质瘤纹理分析对术前危险度分级的预测价值[J]. 医学影像学杂志, 2019, 29(3):420-424. |
[11] | 吕悦, 刘爱连, 刘静红, 等. 能谱单能量图像影像组学在胃癌分级中的应用[J]. 中国医学计算机成像杂志, 2018, 24(5):421-425. |
[12] | 唐雪松, 周宇. 基于增强CT的胃肠道间质瘤纹理分析对术前危险度分级的预测价值[J]. 新疆医科大学学报, 2019, 42(1):91-95. |
[13] | 朱从波, 廖国庆, 赵丁民. Ki-67对胃肠道间质瘤预后的评估价值[J]. 临床与病理杂志, 2018, 38(8):48-55. |
[14] |
Kalfusova A, Hilska I, Krskova L, et al. Gastrointestinal stromal tumors-quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior[J]. Neoplasma, 2016, 63(3):484-492.
doi: 10.4149/320_150714N390 pmid: 26952515 |
[15] | 郭迎雪, 贾建宾, 聂双发, 等. 胃肠道间质瘤主要免疫表型及其与危险度分级和预后的关系[J]. 中国医药导报, 2018, 15(29):110-113. |
[16] | 芦淑娟, 关佳楠. 胃肠间质瘤组织中Ki-67、COX-2、VEGF表达的意义[J]. 热带医学杂志, 2017, 17(4):483-486. |
[1] | Xu Huifeng, Jin Yanyong, Gou Ruolan, Hu Mingzhe. Risk factors for hydrocephalus in children with cerebral hemorrhage and its prediction model [J]. Clinical Focus, 2025, 40(4): 325-328. |
[2] | Zhao Guangyan, Han Tuo, Liang Xiying, Wang Qian, Zhang Yan, Wang Congxia. Risk factors and predictive model for masked hypertension in young and middle-aged adults [J]. Clinical Focus, 2025, 40(3): 205-210. |
[3] | Li Dengfeng, Huang Jiahu, Li Tingjun, Lv Yong, Jin Zhenzhen, Lian Shaofeng. Construction of a prediction model for refractory mycoplasma pneumoniae pneumonia in children based on lung ultrasound score [J]. Clinical Focus, 2025, 40(2): 153-157. |
[4] | Hu Feifei, Wang Fang, Wang Yongni, Huang Shini, Ming Yao. Risk prediction models for weaning failure from mechanical ventilation: A systematic review [J]. Clinical Focus, 2025, 40(2): 107-116. |
[5] | Liu Jinteng, Liu Xingyu, Huang Lumei, Pan Hailong. The risk prediction models for pneumonia in patients with intracerebral hemorrhage: A systematic review [J]. Clinical Focus, 2025, 40(1): 5-13. |
[6] | Zhu Jieyun, Gao Min, Huang Chunli, Pan Dongzan, Wang Qiaoyan, Lu Zhao. Risk prediction model for readmission of chronic obstructive pulmonary disease: A systematic review [J]. Clinical Focus, 2024, 39(9): 773-779. |
[7] | Wang Zhuangzhuang, Ren Huan, Liu Yanting, Tian Chunlei, Ai Wenbing. Construction of a nomogram to predict the risk of lung metastasis in extremity osteosarcomas based on the SEER database and its validation [J]. Clinical Focus, 2024, 39(5): 413-419. |
[8] | Wen Xue, Zhang Zhihua, Zhang Rongjuan, Hao Changlai. Hereditary spherocytosis caused by SPTB gene hybrid mutation: a case report [J]. Clinical Focus, 2021, 36(11): 1019-1023. |
[9] | Lin Yijun, Lin Shan, Wang Shibiao. Prediction factor analysis of infantile bronchopneumonia with acute heart failure [J]. Clinical Focus, 2018, 33(8): 687-690. |
[10] | ZHANG Wen-hua;TANG Rui-feng;BAI Jian-guo;SUN Chao;SHANG Jun-feng;YU Guo-dong;YAO Hong-liang. Expression of proliferating cell nuclear antigen and Ki-67 in intrahepatic cholangiocarcinoma and hepatolithiasis tissue [J]. Clinical Focus, 2014, 29(1): 35-0. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||